Cargando…
Systemic mastocytosis associated with t(8;21)(q22;q22) acute myeloid leukemia
Although KIT mutations are present in 20–25% of cases of t(8;21)(q22;q22) acute myeloid leukemia (AML), concurrent development of systemic mastocytosis (SM) is exceedingly rare. We examined the clinicopathologic features of SM associated with t(8;21)(q22;q22) AML in ten patients (six from our instit...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Springer-Verlag
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713498/ https://www.ncbi.nlm.nih.gov/pubmed/19669220 http://dx.doi.org/10.1007/s12308-009-0023-2 |